NAD Atlas
Explore by ingredientNAD+NRNMNCompare providers

System Labs review

A home-treatment offer that states a 1,000 mg monthly supply.

We may earn a commission from partner links. Our reviews cover both partners and other providers. How we are funded

Where it fits

Good detail on supply and delivery, with renewal pricing still worth confirming.

Reasons to consider it

  • 1,000 mg monthly supply shown
  • Temperature-controlled shipping described

Worth a closer look

  • Renewal rate not explicit enough to normalize
  • Automatic refills require attention

The amount is visible

System Labs labels its NAD offer as a 1,000 mg monthly supply. It also describes injection and nasal routes.

Confirm which route that amount and price refer to rather than assuming both packages match.

The first month is discounted

A $89 first-month offer appears beside $149. The latter should not be assumed to be a fully specified renewal contract.

Ask for the normal refill charge and date in writing.

A recurring home routine

System describes temperature-controlled delivery, automatic refills and the ability to pause or cancel.

The practical question is whether that refill cadence matches your prescribed use and storage instructions.

What to ask before committing

Confirm the full amount due today, renewal terms, and any required consultation, laboratory, medication, supply or shipping fees. Check availability where you live and how you can reach support after signing up.

For prescription care, ask who will evaluate you and which pharmacy would dispense your medication. A provider comparison cannot determine whether a treatment is appropriate for you.

Put the details in context

Compare ingredients and formats Build a cost worksheet Read the research

This is an editorial assessment of published provider information, not a patient testimonial. Offers and availability can change. See our editorial standards.

Before you go

One more option to compare.

We may earn a commission from the partner below. It is a separate provider, and eligibility and treatment decisions require its own evaluation.

Explore partner Continue to your provider